Knight Therapeutics | GUD - Cash And Equivalent



Knight Therapeutics reported CAD5.81M in Cash and Equivalent for its fiscal quarter ending in September of 2024.


Cash And Equivalent Change Date
Acasti Pharma USD 20M 8.94M Jun/2025
Alaunos Therapeutics USD 1.09M 592K Dec/2024
Aurora Cannabis CAD 140.16M 31.45M Jun/2025
Avita Medical AUD 14.05M 3.4M Dec/2024
Canopy Growth CAD 126.2M 109.89M Jun/2025
Cronos Group USD 794.42M 3.4M Jun/2025
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Knight Therapeutics CAD 5.81M 3.59M Sep/2024
Moderna USD 1.28B 344M Jun/2025
Organigram Holdings 35.88M 8.42M Jun/2025
Organon & Co USD 599M 52M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Tectonic Therapeutic USD 287.38M 146.14M Jun/2025
Tilray USD 189.7M 15.49M Nov/2024
Viatris USD 566.4M 188.6M Jun/2025
Xeris Pharmaceuticals USD 59.28M 12.34M Jun/2025